This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Kummer, R. Search for Related Content PubMed PubMed Citation Articles by von Kummer, R.

(Stroke. 2002;33:1446.)
© 2002 American Heart Association, Inc.

Editorials

Brain Hemorrhage After Thrombolysis: Good or Bad?

Rüdiger von Kummer, MD

From the Department of Neuroradiology, Technische Universität, Dresden, Germany.

Correspondence to Rüdiger von Kummer, MD, Technische Universität, Department of Neuroradiology, Fetscherstr 74, Dresden D-01307, Germany. E-mail kummer-r@rcs.urz.tu-dresden.de

Key Words: hemorrhage • reperfusion • thrombolysis • ultrasonography

Intracranial bleeding is the most feared complication of thrombolytic therapy in acute stroke. The risk of brain hemorrhage is the main argument of the European authorities not to approve recombinant tissue plasminogen activator (rtPA), and the fear of hurting patients with rtPA explains its limited use in North America. The common argument is, "Treatment with rt-PA may have some beneficial effect, but that is traded off by a considerable risk of symptomatic hemorrhage."

This argument is false and based on misunderstanding and misconception. The misunderstanding: There is no such trade-off. The National Institute of Neurological Disorders and Stroke (NINDS) rtPA Stroke Study Group observed 2 patients (0.6%) with symptomatic and 1 patient (0.3%) with fatal hemorrhages in the placebo group (n=312) and 20 patients (6.4%) with symptomatic and 9 patients (2.9%) with fatal hemorrhages in the rtPA group (n=312).¹ Despite this supposed excess in risks caused by rtPA treatment (odds ratios [OR], 10.6 and 9.2), rtPA treatment significantly reduced the risk for disability and death (modified Rankin Scale >1 at 12 months after stroke) from 73% to 59% (reduction for death alone: 28% to 24%).² In both European Cooperative Acute Stroke Studies (ECASS) 1 and 2, rtPA increased the risk for parenchymal hematomas (OR, 3.0 and 4.2), but reduced the overall risk for disability and death by 6% and 8% (NS).^3,4 A similar observation—an overall risk reduction for disability and death despite an increased risk for intracranial hemorrhages—was made in the Multicenter Acute Stroke Trials (MAST) -Europe and -Italy.

Why . . . [Full Text of this Article]

This article has been cited by other articles:

				L. Dinia, M. Rubiera, M. Ribo, O. Maisterra, G. Ortega, M. del Sette, J. Alvarez-Sabin, and C. A. Molina Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding Neurology, September 8, 2009; 73(10): 775 - 780. [Abstract] [Full Text] [PDF]

				R. I. Aviv, C. D. d'Esterre, B. D. Murphy, J. J. Hopyan, B. Buck, G. Mallia, V. Li, L. Zhang, S. P. Symons, and T.-Y. Lee Hemorrhagic Transformation of Ischemic Stroke: Prediction with CT Perfusion Radiology, March 1, 2009; 250(3): 867 - 877. [Abstract] [Full Text] [PDF]

				B R Thanvi, S Treadwell, and T Robinson Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors Postgrad. Med. J., July 1, 2008; 84(993): 361 - 367. [Abstract] [Full Text] [PDF]

				J. Fiehler, G. W. Albers, J.-M. Boulanger, L. Derex, A. Gass, N. Hjort, J. S. Kim, D. S. Liebeskind, T. Neumann-Haefelin, S. Pedraza, et al. Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients Stroke, October 1, 2007; 38(10): 2738 - 2744. [Abstract] [Full Text] [PDF]

				J. L. Saver Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm Stroke, August 1, 2007; 38(8): 2279 - 2283. [Abstract] [Full Text] [PDF]

				B. M. Demaerschalk Thrombolytic Therapy for Acute Ischemic Stroke: The Likelihood of Being Helped Versus Harmed Stroke, August 1, 2007; 38(8): 2215 - 2216. [Full Text] [PDF]

				M. Castellanos, T. Sobrino, M. Millan, M. Garcia, J. Arenillas, F. Nombela, D. Brea, N. Perez de la Ossa, J. Serena, J. Vivancos, et al. Serum Cellular Fibronectin and Matrix Metalloproteinase-9 as Screening Biomarkers for the Prediction of Parenchymal Hematoma After Thrombolytic Therapy in Acute Ischemic Stroke: A Multicenter Confirmatory Study Stroke, June 1, 2007; 38(6): 1855 - 1859. [Abstract] [Full Text] [PDF]

				G. Thomalla, J. Sobesky, M. Kohrmann, J. B. Fiebach, J. Fiehler, O. Zaro Weber, A. Kruetzelmann, T. Kucinski, M. Rosenkranz, J. Rother, et al. Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of Ischemia: MRI Study of Acute Stroke Patients Treated With Intravenous Tissue Plasminogen Activator Within 6 Hours Stroke, February 1, 2007; 38(2): 313 - 318. [Abstract] [Full Text] [PDF]

				I. Dzialowski, J. H. W. Pexman, P. A. Barber, A. M. Demchuk, A. M. Buchan, M. D. Hill, and on behalf of the CASES Investigators Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry Stroke, January 1, 2007; 38(1): 75 - 79. [Abstract] [Full Text] [PDF]

				K. Z. Bambauer, S. C. Johnston, D. E. Bambauer, and J. A. Zivin Nonstroke Treatment--Reply Arch Neurol, October 1, 2006; 63(10): 1506 - 1507. [Full Text] [PDF]

				The IMS Study Investigators Hemorrhage in the Interventional Management of Stroke Study Stroke, March 1, 2006; 37(3): 847 - 851. [Abstract] [Full Text] [PDF]

				P. Trouillas and R. von Kummer Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke Stroke, February 1, 2006; 37(2): 556 - 561. [Abstract] [Full Text] [PDF]

				J. L. Saver Number Needed to Treat Estimates Incorporating Effects Over the Entire Range of Clinical Outcomes: Novel Derivation Method and Application to Thrombolytic Therapy for Acute Stroke Arch Neurol, July 1, 2004; 61(7): 1066 - 1070. [Abstract] [Full Text] [PDF]

				M.-C. Arnould, C. B. Grandin, A. Peeters, G. Cosnard, and T. P. Duprez Comparison of CT and Three MR Sequences for Detecting and Categorizing Early (48 Hours) Hemorrhagic Transformation inHyperacute Ischemic Stroke AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 939 - 944. [Abstract] [Full Text] [PDF]

				C.S. Gray and J.E. O'Connell Stroke: beyond thrombolysis and back to basics QJM, March 1, 2003; 96(3): 179 - 181. [Full Text] [PDF]